SCHEMBL740825

SCHEMBL740825

COCCCn1c(C2CCCN(C(=O)CC(N)Cc3ccc(-c4ccnc(O)c4)cc3)C2)nc2c(F)cccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 2/20 0.36
DPP4 P27487 6/20 0.34
CYP2D6 P10635 3/20 0.34
HRH1 P35367 2/20 0.34
BTK Q06187 5/20 0.33
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
DPP9 Q86TI2 2/20 0.32
KCNH2 Q12809 2/20 0.32
LCK P06239 1/20 0.32
FYN P06241 1/20 0.32
YES1 P07947 1/20 0.32
LYN P07948 1/20 0.32
FGR P09769 1/20 0.32
SRC P12931 1/20 0.32
CSK P41240 1/20 0.32
TEC P42680 1/20 0.32
TXK P42681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740824 1.00 CFD (0.36) CFDDPP4CYP2D6HRH1BTK
SCHEMBL742008 0.92 CFD (0.35) CFDDPP4CYP2D6HRH1BTK
SCHEMBL742009 0.92 CFD (0.35) CFDDPP4CYP2D6HRH1BTK
SCHEMBL740772 0.90 HTT (0.39) CFDDPP4CYP2D6HRH1BTK
SCHEMBL740771 0.90 HTT (0.39) CFDDPP4CYP2D6HRH1BTK
SCHEMBL741424 0.90 CFD (0.36) CFDDPP4CYP2D6HRH1BTK
SCHEMBL741425 0.90 CFD (0.36) CFDDPP4CYP2D6HRH1BTK
SCHEMBL741237 0.89 KCNH2 (0.42) CYP2D6HRH1KCNH2
SCHEMBL741236 0.89 KCNH2 (0.42) CYP2D6HRH1KCNH2
SCHEMBL741441 0.89 CFD (0.36) CFDDPP4CYP2D6HRH1BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US claimed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed